Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,148 GBX | -0.18% | +7.88% | +14.68% |
11:24am | AstraZeneca: encouraging results in lymphoma | CF |
11:06am | AstraZeneca notes positive trial results for Calquence treatment | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.68% | 236B | |
+33.25% | 699B | |
+27.37% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+4.47% | 198B | |
-11.04% | 194B | |
-5.59% | 154B | |
-3.69% | 149B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Provides Positive Update on Drug to Treat Infants at High Risk of Respiratory Syncytial Virus